Healthpeak Properties, Inc. (NYSE:DOC) Director Tommy G. Thompson Purchases 5,700 Shares

Healthpeak Properties, Inc. (NYSE:DOC) Director Tommy G. Thompson bought 5,700 shares of the business’s stock in a transaction dated Friday, May 9th. The shares were acquired at an average cost of $17.36 per share, for a total transaction of $98,952.00. Following the purchase, the director now owns 138,513 shares of the company’s stock, valued at approximately $2,404,585.68. The trade was a 4.29% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Healthpeak Properties Stock Down 1.7%

Shares of NYSE DOC opened at $17.25 on Wednesday. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $11.98 billion, a PE ratio of 49.29, a price-to-earnings-growth ratio of 2.17 and a beta of 1.05. The stock’s fifty day simple moving average is $19.02 and its two-hundred day simple moving average is $20.19. Healthpeak Properties, Inc. has a 12-month low of $17.15 and a 12-month high of $23.26.

Healthpeak Properties (NYSE:DOC) last announced its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. The business had revenue of $702.89 million for the quarter, compared to analysts’ expectations of $690.76 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The business’s revenue for the quarter was up 15.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.45 EPS. As a group, analysts expect that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, April 30th. Stockholders of record on Friday, April 18th were issued a dividend of $0.1017 per share. The ex-dividend date of this dividend was Thursday, April 17th. This represents a dividend yield of 6.5%. Healthpeak Properties’s dividend payout ratio is presently 305.00%.

Institutional Trading of Healthpeak Properties

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Invesco Ltd. lifted its holdings in shares of Healthpeak Properties by 20.7% during the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust’s stock valued at $467,311,000 after purchasing an additional 3,967,830 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after purchasing an additional 4,056,931 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Healthpeak Properties by 3.6% during the 4th quarter. Geode Capital Management LLC now owns 18,355,772 shares of the real estate investment trust’s stock valued at $371,168,000 after purchasing an additional 638,012 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Healthpeak Properties by 2,113.5% during the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock valued at $367,575,000 after purchasing an additional 17,314,572 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Healthpeak Properties by 10.6% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 17,267,917 shares of the real estate investment trust’s stock valued at $350,021,000 after purchasing an additional 1,651,235 shares during the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price on the stock in a research note on Wednesday, January 15th. Wedbush cut their target price on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a research note on Monday, April 28th. Scotiabank cut their target price on Healthpeak Properties from $23.00 to $21.00 and set a “sector outperform” rating on the stock in a research note on Monday. Robert W. Baird cut their target price on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 29th. Finally, StockNews.com cut Healthpeak Properties from a “hold” rating to a “sell” rating in a research note on Thursday, May 1st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $23.25.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.